Analysts/Institutional Investor Meet/Con. Call Updates

Date: 06 August, 2026 The Secretary The Secretary BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1. G Block Dalal Street Bandra -Kurla Complex, Bandra (East) Mumbai - 400 001 Mumbai- 400 051 Scrip Code: 544293 Scrip Symbol : SURAKSHA Dear Sir / Ma’am, Sub: Intimation of schedule of Analysts / Institutional Investors / Organizations meet Ref: Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Company will host a Conference Call viz. ‘Earnings Call’ for the Analysts/Institutional Investors/ Organizations as below: Type of Day, Date & Time Event Mode meeting Thursday, 13 August, Discussion on Q1 Virtual/Digital 2026 financial results means Group meet No unpublished price-sensitive information is proposed to be shared during the aforesaid Earnings Call. Discussions at the event will be based on information that is publicly available. The Investor Presentation on the Unaudited financial performance of the Company for the quarter ended 30 June 2026 will be presented and discussed at the aforesaid meeting and the same shall be made available on the website of the Company at www.surakshanet.com. Please note that the schedule of the aforesaid Earnings Call is subject to change. The changes might happen due to exigencies on the part of the Company/Analysts/Institutional Investors/ Organizations. Further, details as required to be disclosed as per BSE Circular No.: 20230714-34 dated 14 July 2023, and NSE Circular No.: NSE/CML/2023/57 dated 14 July 2023 are as under: Date of occurrence of event/information: Thursday, 13 August, 2026 Time of occurrence of event/information: 11:30 A.M. (IST) Suraksha Diagnostic Limited CIN: L85110WB2005PLC102265 Reg Office: 12/1, Premises No. 02-0327, DG Block, Action Area 1D, New Town, Kolkata-700 156, West Bengal, India E-mail: investors@surakshanet.com I Website: www.surakshanet.com Phone:(033) 6605 9750 The invitation of the aforesaid Earnings Call is enclosed herewith. This may please be informed to all the concerned. For Suraksha Diagnostic Limited Ritu Mittal Joint Managing Director & CEO DIN: 00165886 Suraksha Diagnostic Limited CIN: L85110WB2005PLC102265 Reg Office: 12/1, Premises No. 02-0327, DG Block, Action Area 1D, New Town, Kolkata-700 156, West Bengal, India E-mail: investors@surakshanet.com I Website: www.surakshanet.com Phone:(033) 6605 9750 SURAKSHA DIAGNOSTIC LIMITED Suraksha Diagnostic Limited will host a conference call for analysts and investors to discuss their Q1 FY27 results Date and Time: Thursday, 13th August 2026, at 11:30 AM IST COMPANY PARTICIPANTS Dr. Somnath Chatterjee (Chairman & Joint Managing Director) Ms. Ritu Mittal (Joint Managing Director & Chief Executive Officer) Mr. Bablu Shaw (General Manager - Finance) Mr. Niren Kaul (Chief Sales Officer) Mr. Balgopal Jhunjhunwala (Regional Business Head) CONFERENCE DIAL IN NUMBERS Universal Dial In : +91 22 6280 1550 / +91 22 7115 8378 International Toll Free: Hong Kong : 800964448 UK : 08081011573 Singapore : 8001012045 USA : 18667462133 Please pre-register to avoid wait time: DIAMOND PASS Please click here for pre-registration RSVP Suraksha Diagnostic Limited MUFG Intime India Private Limited Investor Relations Team Omkar Bagwe / Sumeet Khaitan investors@surakshanet.com omkar.bagwe@in.mpms.mufg.com sumeet.khaitan@in.mpms.mufg.com